The store will not work correctly when cookies are disabled.
4-hydroxy-6-(4-methoxyphenethyl)pyridazin-3(2H)-one
ID: ALA2338802
PubChem CID: 71655735
Max Phase: Preclinical
Molecular Formula: C13H14N2O3
Molecular Weight: 246.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(CCc2cc(O)c(=O)[nH]n2)cc1
Standard InChI: InChI=1S/C13H14N2O3/c1-18-11-6-3-9(4-7-11)2-5-10-8-12(16)13(17)15-14-10/h3-4,6-8H,2,5H2,1H3,(H,14,16)(H,15,17)
Standard InChI Key: YDXOZGMGXDPRQB-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
6.0381 -21.6886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0381 -22.5099 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7475 -22.9185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4569 -22.5099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4569 -21.6886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7475 -21.2759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1682 -22.9237 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1700 -21.2821 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3251 -21.2821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6145 -21.6927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9014 -21.2862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9030 -20.4659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1949 -20.0553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4833 -20.4702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4884 -21.2957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2011 -21.6985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7698 -20.0605 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7663 -19.2392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
4 7 2 0
5 8 1 0
1 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
14 17 1 0
17 18 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 246.27 | Molecular Weight (Monoisotopic): 246.1004 | AlogP: 1.27 | #Rotatable Bonds: 4 |
Polar Surface Area: 75.21 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.84 | CX Basic pKa: ┄ | CX LogP: 1.58 | CX LogD: 1.44 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.85 | Np Likeness Score: -0.45 |
References
1. Hondo T, Warizaya M, Niimi T, Namatame I, Yamaguchi T, Nakanishi K, Hamajima T, Harada K, Sakashita H, Matsumoto Y, Orita M, Takeuchi M.. (2013) 4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors., 56 (9): [PMID:23566269] [10.1021/jm400095b] |